Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-26-019737
Filing Date
2026-05-08
Accepted
2026-05-08 08:17:43
Documents
14
Effectiveness Date
2026-05-08

Document Format Files

Seq Description Document Type Size
1 S-8 ef20072226_s-8.htm S-8 59078
2 EXHIBIT 5.1 ef20072226_ex5-1.htm EX-5.1 94858
3 EXHIBIT 23.1 ef20072226_ex23-1.htm EX-23.1 3070
4 EXHIBIT 107 ef20072226_ex107.htm   iXBRL EX-FILING FEES 16307
5 image00001.jpg GRAPHIC 2777
  Complete submission text file 0001140361-26-019737.txt   299533

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20072226_ex107_htm.xml XML 5789
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-295682 | Film No.: 26956174
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)